Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surmodics, Inc. - Common Stock (NQ:SRDX)

28.32 +0.89 (+3.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surmodics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 300 points on Thursday. 
Via Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday. 
Via Benzinga
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
 
Via Benzinga
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
From Surmodics, Inc.
Via Business Wire
Surmodics: Q3 Earnings Insights
  Surmodics (NASDAQ:SRDX) reported its Q3 earnings results on Wednesday, July 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Surmodics Q2 Earnings
Surmodics (NASDAQ:SRDX) reported its Q2 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
From Surmodics, Inc.
Via Business Wire
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
From Surmodics, Inc.
Via Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
From Surmodics, Inc.
Via Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
From Surmodics, Inc.
Via Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
From Surmodics, Inc.
Via Business Wire
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
From Surmodics, Inc.
Via Business Wire
Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
From Surmodics, Inc.
Via Business Wire
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
From Surmodics, Inc.
Via Business Wire
Surmodics Reports Third Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
A Preview Of Surmodics's Earnings
Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will... 
Via Benzinga
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. 
Via Benzinga
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
From Surmodics, Inc.
Via Business Wire
Surmodics to Present at Jefferies Healthcare Conference
From Surmodics, Inc.
Via Business Wire
Surmodics Reports Second Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases
From Surmodics, Inc.
Via Business Wire
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
From Surmodics, Inc.
Via Business Wire
Surmodics Q2 2022 Earnings Conference Call On April 27, 2022 At 08:30 AM ET
Surmodics (NASDAQ:SRDX) will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q2 2022 earnings results. How to Attend Surmodics (SRDX) Conference Call Follow this link to access the... 
Via Benzinga
Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27
From Surmodics, Inc.
Via Business Wire
Earnings Scheduled For April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.